Maestros Electronics & Telecommunications Systems Ltd (METSL) Fair Value & Analysis
Healthcare · IN · Market cap ₹737M
Fair value as of: Aug 16, 2026
From 17 valuation models · updated 4 days ago
A solid business, screening 55% undervalued on our models.
What matters now
- The model range is unusually wide (₹89.52 to ₹272.44). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- Solid quality (60/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 16, 2026.
How to read this chart
60‑month range ₹43.50 – ₹249.55 · fair‑value band ₹89.52 – ₹272.44 · the ₹139.90 price screens below the ₹217.47 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 16, 2026.
Analysis
Maestros Electronics & Telecommunications Systems Ltd (METSL) currently trades at ₹139.90, while our model-based Fair Value estimate is ₹217.47, implying the stock looks roughly 55.5% undervalued today. The Quality Score stands at 60/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Maestros Electronics & Telecommunications Systems Ltd generated revenue of ₹394M at a net margin of 18.4%. Revenue grew 51.7% year over year. It earns a return on equity of 18.8%. Net debt stands at ₹13.3M. Fundamentals as of Aug 16, 2026
Our scenario range runs from ₹89.52 (bear case) to ₹272.44 (bull case); at ₹139.90, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 24% below its 52-week high and 31% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at -33% fair-value upside, at 55%, METSL screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 17 models by family
Widest divergence: Growth Earnings (₹556.14) versus Dividend Discount (₹6.39). Highest evidence: Residual Income (76).
Notify me when METSL reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 16, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 57 · Market factors (momentum, volatility) 49
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Maestros Electronics & Telecommunications Systems Limited manufactures and sells medical equipment and telemedicine products in India. It operates through two segments, Electronics and Instrumentation, and Telemedicine.
Full company description
Maestros Electronics & Telecommunications Systems Limited manufactures and sells medical equipment and telemedicine products in India. It operates through two segments, Electronics and Instrumentation, and Telemedicine. The company offers critical care products, such as ECG machines, patient monitors, defibrillators, pulse oximeters, spirometer, syringe pumps, and stress test machines; mother and child care products, including fetal monitors; and telemedicine solutions. Maestros Electronics & Telecommunications Systems Limited was incorporated in 2010 and is based in Mumbai, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Maestros Electronics & Telecommunications Systems Ltd reported revenue of ₹394M in FY2026 versus ₹111M in FY2022, a compound +37.1%/yr. Reported net income was ₹72.5M in FY2026, compounding +55.1%/yr from FY2022.
Watch METSL: get an alert when its fair value changes →
Peer Group
Medical Devices · 362 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Devices median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Devices stocks, each showing price versus our Fair Value estimate (as of Aug 16, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Abbott Laboratories, ABT | $110.91 | $74.79 | -33% |
| Stryker Corporation SYK | $347.21 | $186.28 | -46% |
| Medtronic plc MDT | $90.76 | $65.57 | -28% |
| Boston Scientific Corporation BSX | $51.42 | $38.44 | -25% |
| Shenzhen Mindray Bio-Medical Electronics Co 300760 | ¥150.63 | ¥147.63 | -2% |
| Shanghai United Imaging Healthcare Co 688271 | ¥110.50 | ¥43.60 | -61% |
| Demant A/S DEMANT | kr 289.60 | kr 161.17 | -44% |
| Getinge AB GETIB | kr 240.60 | kr 192.14 | -20% |
| Sectra AB SECTB | kr 280.00 | kr 66.81 | -76% |
| CLASSYS Inc 214150 | 39,700 KRW | 20,415 KRW | -49% |
Compare Maestros Electronics & Telecommunications Systems Ltd with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Maestros Electronics & Telecommunications Systems Ltd (METSL) overvalued or undervalued?
What is the fair value of METSL?
What is the quality score of METSL?
What is the revenue of Maestros Electronics & Telecommunications Systems Ltd (METSL)?
What is the net profit margin of METSL?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Maestros Electronics & Telecommunications Systems Ltd and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.